Lecturer at the Department of Computer Science, Govt. Degree College Sumbal, J&K, India.
Research Coordinator at KWINTECH-R LABS (V), Kwintech-Rlabs(V), J&K, India.
J Healthc Eng. 2022 Apr 12;2022:9882288. doi: 10.1155/2022/9882288. eCollection 2022.
Heart disease is a severe disorder, which inflicts an adverse burden on all societies and leads to prolonged suffering and disability. We developed a risk evaluation model based on visible low-cost significant noninvasive attributes using hyperparameter optimization of machine learning techniques. The multiple set of risk attributes is selected and ranked by the recursive feature elimination technique. The assigned rank and value to each attribute are validated and approved by the choice of medical domain experts. The enhancements of applying specific optimized techniques like decision tree, k-nearest neighbor, random forest, and support vector machine to the risk attributes are tested. Experimental results show that the optimized random forest risk model outperforms other models with the highest sensitivity, specificity, precision, accuracy, AUROC score, and minimum misclassification rate. We simulate the results with the prevailing research; they show that it can do better than the existing risk assessment models with exceptional predictive accuracy. The model is applicable in rural areas where people lack an adequate supply of primary healthcare services and encounter barriers to benefit from integrated elementary healthcare advances for initial prediction. Although this research develops a low-cost risk evaluation model, additional research is needed to understand newly identified discoveries about the disease.
心脏病是一种严重的疾病,给所有社会带来了沉重的负担,导致人们长期受苦和残疾。我们使用机器学习技术的超参数优化,开发了一个基于可见的低成本显著无创属性的风险评估模型。通过递归特征消除技术选择和对风险属性进行排名。每个属性的分配等级和值都经过医疗领域专家的选择进行验证和批准。我们还测试了将特定优化技术(如决策树、k 最近邻、随机森林和支持向量机)应用于风险属性的效果。实验结果表明,优化后的随机森林风险模型在灵敏度、特异性、精度、准确性、AUROC 评分和最小误分类率方面表现优于其他模型。我们对现有研究结果进行了模拟,结果表明,它在预测准确率方面优于现有的风险评估模型。该模型适用于农村地区,在这些地区,人们缺乏足够的初级医疗保健服务供应,并且难以从综合初级医疗保健进步中受益,因此可以进行初步预测。尽管这项研究开发了一种低成本的风险评估模型,但需要进一步研究来了解该疾病的新发现。